Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Schisandrol B is a lignan originally isolated from S. chinensis that has hepatoprotective activity.1 It increases the expression of pregnane X receptor (PXR) target genes involved in bile acid metabolism, including Cyp3a11, Ugt1a1, Oatp2, and Mrp3 in mouse liver and CYP3A4, UGT1A1, and OATP2 in HEK293T cells.2 It also protects against lithocholic acid-induced hepatic necrosis and intrahepatic cholestasis in wild-type, but not Pxr-null, mice and decreases mortality in a mouse model of cholestasis when administered at a dose of 100 mg/kg twice per day. It also promotes liver regeneration following partial hepatectomy and protects against hepatotoxicity induced by acetaminophen (Item No. 10024).3,4
WARNING This product is not for human or veterinary use.
1. The constituents of Schizandra chinensis BAILL. I. The structures of gomisin A, B and C. Chem. Pharm. Bull. 23(12), 3296-3298 (1975).
2. Schisandrol B protects against cholestatic liver injury through pregnane X receptors. Br. J. Pharmacol. 174(8), 672-688 (2017).
3. Schisandrol B promotes liver regeneration after partial hepatectomy in mice. Eur. J. Pharmacol. 818, 96-102 (2018).
4. Schisandrol B protects against acetaminopheninduced acute hepatotoxicity in mice via activation of the NRF2/ARE signaling pathway. Acta Pharmacol. Sin. 37(3), 382-389 (2016).